Cas 906071-12-3,1-(4-Chloro-3-methoxy-phenyl)-3,3,5,5-tetramethyl-[1,4]diazepane

906071-12-3

Post Buying Request

Basic information

Product Name: 1-(4-Chloro-3-methoxy-phenyl)-3,3,5,5-tetramethyl-[1,4]diazepane
Synonyms: 1-(4-Chloro-3-methoxy-phenyl)-3,3,5,5-tetramethyl-[1,4]diazepane
CAS NO:906071-12-3
Molecular Formula:
Molecular Weight: 296.84
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-(4-Chloro-3-methoxy-phenyl)-3,3,5,5-tetramethyl-[1,4]diazepane(CAS DataBase Reference)
NIST Chemistry Reference: 1-(4-Chloro-3-methoxy-phenyl)-3,3,5,5-tetramethyl-[1,4]diazepane(906071-12-3)
EPA Substance Registry System: 1-(4-Chloro-3-methoxy-phenyl)-3,3,5,5-tetramethyl-[1,4]diazepane(906071-12-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 906071-12-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

906071-12-3 Suppliers

Recommended suppliers

906071-12-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 906071-12-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,6,0,7 and 1 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 906071-12:
(8*9)+(7*0)+(6*6)+(5*0)+(4*7)+(3*1)+(2*1)+(1*2)=143
143 % 10 = 3
So 906071-12-3 is a valid CAS Registry Number.

906071-12-3Upstream product

906071-12-3Downstream Products

906071-12-3Relevant academic research and scientific papers

Novel Alkyl Substituted Homopiperazine Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors

-

Page/Page column 6, (2008/12/05)

This invention relates to novel alkyl substituted homopiperazine derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 906071-12-3